Custom immune cells take on advanced colorectal cancer in new trial
NCT ID NCT07504523
First seen Apr 12, 2026 · Last updated Apr 26, 2026 · Updated 2 times
Summary
This early-stage trial is testing a personalized T-cell therapy called iNeo-Vac-T01 for people with advanced colorectal cancer that has spread. The treatment is made from each patient's own immune cells, which are trained to recognize unique markers on their tumor. The study will enroll 20 patients to check if the therapy is safe, feasible, and shows any signs of shrinking tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITINGHangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.